- Home
- MOLN vs FORR Comparison
MOLN vs FORR Comparison
Compare MOLN & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- FORR
- Stock Information
- Founded
- MOLN 2004
- FORR 1983
- Country
- MOLN Switzerland
- FORR United States
- Employees
- MOLN N/A
- FORR N/A
- Industry
- MOLN
- FORR Diversified Commercial Services
- Sector
- MOLN
- FORR Consumer Discretionary
- Exchange
- MOLN Nasdaq
- FORR Nasdaq
- Market Cap
- MOLN 183.2M
- FORR 179.6M
- IPO Year
- MOLN 2021
- FORR 1996
- Fundamental
- Price
- MOLN $3.81
- FORR $10.63
- Analyst Decision
- MOLN
- FORR
- Analyst Count
- MOLN 0
- FORR 0
- Target Price
- MOLN N/A
- FORR N/A
- AVG Volume (30 Days)
- MOLN 3.2K
- FORR 68.0K
- Earning Date
- MOLN 05-15-2025
- FORR 05-06-2025
- Dividend Yield
- MOLN N/A
- FORR N/A
- EPS Growth
- MOLN N/A
- FORR N/A
- EPS
- MOLN N/A
- FORR N/A
- Revenue
- MOLN $2,525,030.00
- FORR $422,269,000.00
- Revenue This Year
- MOLN N/A
- FORR N/A
- Revenue Next Year
- MOLN $866.67
- FORR $2.04
- P/E Ratio
- MOLN N/A
- FORR N/A
- Revenue Growth
- MOLN N/A
- FORR N/A
- 52 Week Low
- MOLN $3.36
- FORR $8.50
- 52 Week High
- MOLN $12.70
- FORR $20.62
- Technical
- Relative Strength Index (RSI)
- MOLN 46.07
- FORR 55.44
- Support Level
- MOLN $3.58
- FORR $10.39
- Resistance Level
- MOLN $4.11
- FORR $10.91
- Average True Range (ATR)
- MOLN 0.12
- FORR 0.46
- MACD
- MOLN -0.02
- FORR 0.00
- Stochastic Oscillator
- MOLN 33.74
- FORR 67.59
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.